An elevated bone microenvironmental reactive oxygen species
(ROS)
level is a hallmark of osteoporosis that often leads to the dysfunction
of bone-related mesenchymal stem cells (MSCs), which would induce
MSC senescence and severely undermine their osteoblastic potential.
Herein, we report the in situ construction of bone
microenvironment-responsive biofunctional metal–organic framework
(bio-MOF) coating on the titanium surface through the coordination
between p-xylylenebisphosphonate (PXBP) and Ce/Sr
ions by a hydrothermal method. Taking advantage of the anchored Ce
and Sr ions, the AHT-Ce/SrMOF implants demonstrate on-demand superoxide
dismutase and catalase-like catalytic activities to decompose ROS
in MSCs and restore their mitochondrial functions. In vitro analysis showed that the AHT-Ce/SrMOF implants substantially activated
the AMP-activated protein kinase (AMPK) signaling pathway in MSCs
and reduced the ROS levels. Meanwhile, MSCs grown on AHT-Ce/SrMOF
implants displayed significantly higher expressions of the mitochondrial
fission marker (DRP1), mitochondrial fusion marker (MFN2 and OPA1),
and mitophagy marker (PINK1 and LC3) than those of the AHT-CeMOF and
AHT-SrMOF groups, which indicated that the bio-MOF could amend mitochondrial
function in MSCs to reverse senescence. In vivo evaluations
showed that the bio-MOF-coated Ti implants could restore MSC function
in the implant site and promote new bone formation, leading to improved
osteointegration in osteoporotic rat. This study may improve implant-mediated
fracture healing in the clinics.